Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: a post hoc analysis of the X-VeRT trial.
Europace
; 18(2): 184-90, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-26487668
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Atrial Fibrillation
/
Warfarin
/
Budgets
/
Electric Countershock
/
Patient Satisfaction
/
Drug Costs
/
Factor Xa Inhibitors
/
Rivaroxaban
/
Anticoagulants
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
Europace
Journal subject:
CARDIOLOGIA
/
FISIOLOGIA
Year:
2016
Type:
Article
Affiliation country:
Germany